000710.SZ · 贝瑞基因
China A-shares · RS rating 92 · As of 2026-10-14
| Price | 10.56 CNY |
|---|---|
| 1-day change | -4.9% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 97 / 96 / 42 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 31 / 32 |
| Industry group (rank) | Medical-Research Eqp/Svc (6) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +12.5% |
| Distance from 52-week high | +29.6% |
| Market cap (USD) | $597.4M |